探讨冠心病慢性心力衰竭患者室性心律失常临床治疗韩荣晶 刘莉.docVIP

精品论文 参考文献 探讨冠心病慢性心力衰竭患者室性心律失常临床治疗韩荣晶 刘莉 黑龙江省鹤岗市人民医院 154101 【摘 要】目的：研究分析冠心病慢性心力衰竭患者发生室性心律失常后临床疗效。方法：此次研究的对象是选择在2012年2月-2014年12月入住我院接受治疗的98例冠心病慢性心力衰竭室性心律失常患者，将其临床资料进行回顾性分析，并经抽签方式随机分为对照组（n=49）、试验组（n=49）。对照组采用常规治疗措施，试验组患者在对照组治疗的基础上加用胺碘酮，对两组疗效进行对比。结果：对照组治疗有效率（71.43%）显著低于试验组（90.20%），试验组不良反应发生率（4.08%）显著低于对照组（28.56%），两组比较差异均有统计学意义（Plt;0.05）。结论：冠心病慢性心力衰竭患者室性心律失常的临床治疗中，加用胺碘酮药物可以有效改善患者临床治疗效果，可有效控制患者心率失常等不良症状的发生，值得在临床推广应用。 【关键词】冠心病；慢性心力衰竭；心律失常 Abstract：Objective：To study the clinical effect of ventricular arrhythmias in patients with coronary heart disease and chronic heart failure.Methods：the research object is selected in February 2012 - 2014 years December admitted to our hospital to accept the treatment of 98 cases of chronic heart failure of coronary heart disease ventricular cardiac arrhythmia patients，their clinical data were retrospectively analyzed，and the drawing of lots were divided for the control group（n = 49）and experimental group（n = 49）.The control group was treated with routine treatment，the patients in the experimental group were treated with amiodarone on the basis of the control group，and the efficacy of the two groups were compared.Results：in treatment group and control group with efficiency（71.43%）was significantly lower than that in the test group（90.20%），test group，the adverse reaction occurred rate（4.08%）was significantly lower than that of control group（28.56%），two group differences were statistically significant（P lt; 0.05）.Conclusion：in the clinical treatment of chronic heart failure of coronary heart disease patients with ventricular arrhythmia and drug amiodarone can effectively improve the clinical treatment effect，can effectively control the patients with arrhythmia and other adverse symptoms occurred，worthy of clinical application. Key words：coronary heart disease；chronic heart failure；arrhythmia 心力衰竭是临床常见疾病，高血压、冠心病、心脏病等均可引起心力衰竭。心力衰竭患者可出现运动耐力下降、体液潴留等症状，还可出现心功能不全、心脏扩大等[1]。心力衰竭患者较易出现室性心律失常，且往往与室性心律失常同时发生，疾病的发展速度较快，可严重威胁患者的生命健康，增加患者的经济负